There were 1,506 press releases posted in the last 24 hours and 435,508 in the last 365 days.

Global Clinical Trial Market is projected to reach USD 62.5 Billion by 2025, at a CAGR of 5.7% During Forecast Period

Clinical Trial Market is segmented based on Phase, Design, Indication and geography.

PUNE, MAHARASHTRA, INDIA, January 29, 2019 /EINPresswire.com/ -- Clinical trials, research studies performed on humans, are designed to gain specific information about biomedical interventions such as vaccines, treatments and drugs in order to prove the safety and efficacy of the products.
The Clinical Trial Market accounted for USD 43.7 Billion in 2018 and is projected to reach USD 62.5 Billion by 2025, at a CAGR of 5.7% over the forecast period.

The driving factor of Clinical Trial Market is globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials.

To Browse Complete report visit @ https://www.ozonemarketreports.com/pharmaceuticals-and-healthcare/global-clinical-trial-market-research-report/26981

Globalization of clinical trial has led to increase in investment in new product development in emerging countries thereby, having a positive impact on overall market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the life for mid-size and small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource what they think is beyond their core expertise. For instance, Pfizer currently has three CROs working with it to enhance its product portfolio and drive innovation. According to the partnership agreement with ICON in 2011, Pfizer would only preserve the scientific ownership for the trials and studies conducted by ICON, hence allowing the company to focus and further develop its capabilities in clinical trial designing.

By region, North America has dominated the Clinical Trial Market and has generated USD XX million market value in 2017 and is estimated to reach USD XX million market by 2025 with growing XX% CAGR. The region has dominated the market as it has presence of big outsourcing firms and increasing R&D in the region.
The major participants in the global Clinical Trial Market include Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA, Chiltern, Omnicare, PPD, Kendle and others.

Market Segmentation:
Clinical Trial Market is segmented based on Phase, Design, Indication and geography.

Market segmented by Phase
•Phase I
•Phase II
•Phase III
•Phase IV

Market segmented by Design
•Treatment Studies
•Randomized Control Trial
•Adaptive Clinical TrialNon-Randomized Control Trial
•Observational Studies
•Cohort Study
•Case Control Study
•Cross Sectional Study
•Ecological Study
•Expanded Access

To Get Free Sample Request Report visit @ https://www.ozonemarketreports.com/sample-request/global-clinical-trial-market-research-report/26981

Market segmented by Indication
• Autoimmune/inflammation
• Pain management
• Oncology
• CNS condition
• Diabetes
• Obesity
• Cardiovascular
Market segmented by region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Key Players
• Quintiles IMS
• Paraxel International Corporation
• Charles River Laboratories
• ICON plc
• SGS SA
• Chiltern
• Omnicare
• PPD
• Kendle

To Browse Similar Reports: https://www.ozonemarketreports.com/category/pharmaceuticals-and-healthcare/11

ABOUT US
Ozone Market Reports is committed towards delivering intensive research based analysis reports, enabling clients to easily make fact-based decisions. We also have with us the facility of our innovatively designed and developed data processing and analysis division.
Ozone Market Reports is a research-based consulting firm specializing in getting research inputs and using them appropriately in the marketing planning process. In saying this, we are trying to convey that we always attempt to interpret the research data from the viewpoint of recommending action
3priorities - both short-term and long-term. To this end, we have put together a team that understands not only research techniques, but also branding concepts in depth. We believe our people are our clients' biggest assets hence we do our best to recruit multi-skilled individuals, and then give them an environment where they can think and ideate freely.
We offer various services for our clients to help them choose what's most relevant and best for them required for their business.

Himesh khatri
Ozone Market Reports
+91 9370882135
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.